ScholarIQanswers from OpenAlex
Peter MacCallum Cancer Centre
InstitutionResearch output, impact & collaborations
Peter MacCallum Cancer Centre is a institution indexed in ScholarIQ from OpenAlex.
What is known about Peter MacCallum Cancer Centre?
ScholarIQrecord summary
Peter MacCallum Cancer Centre is a research organisation in Melbourne, AU. OpenAlex records 24,570 works and 3,931,648 citations for it. 4,446 researchers list it as their most recent affiliation.
How many works does Peter MacCallum Cancer Centre have?
ScholarIQindexed works
Peter MacCallum Cancer Centre has 24,570 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter MacCallum Cancer Centre have?
ScholarIQcitation count
Peter MacCallum Cancer Centre has 3,931,648 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Peter MacCallum Cancer Centre?
ScholarIQresearcher count
Peter MacCallum Cancer Centre has 4,446 researchers in the ScholarIQ index.
What is the average h-index at Peter MacCallum Cancer Centre?
ScholarIQavg h-index
Peter MacCallum Cancer Centre has an average h-index of 51.9 in OpenAlex.
What is the ROR of Peter MacCallum Cancer Centre?
ScholarIQror
The ROR for Peter MacCallum Cancer Centre is on the source record.
What is the OpenAlex record for Peter MacCallum Cancer Centre?
ScholarIQopenalex
The OpenAlex for Peter MacCallum Cancer Centre is on the source record.
Who are the most-cited researchers behind Peter MacCallum Cancer Centre?
ScholarIQtop researchers by citations
What are the most-cited papers on Peter MacCallum Cancer Centre?
ScholarIQmost cited works
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
S. Hacein-Bey-Abina, Christof von Kalle, Manfred Schmidt, Matthew P. McCormack, N. M. Wulffraat, Philippe Leboulch, Apiradee Lim, Cameron S. Osborne, Robert Pawliuk, Estelle Morillon, Ricardo U. Sorensen, A. Förster, Peter Fraser, J. I. Cohen, Geneviève de Saint Basile, Ian E. Alexander, Uwe Wintergerst, Thierry Frébourg, Alain Aurias, Dominique Stoppa‐Lyonnet, Serge Romana, I Radford-Weiss, Fabian Gross, F Valensi, Éric Delabesse, Elizabeth Macintyre, F Sigaux, Jean Soulier, Lily E. Leiva, Manuela Wissler, Claudia Prinz, Terence H. Rabbitts, Françoise Le Deist, Alain Fischer, Marina Cavazzana
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman, Ray McDermott, Joseph L. Leach, Sara Lonardi, Heinz‐Josef Lenz, Michael A. Morse, Jayesh Desai, Andrew Hill, Michael D. Axelson, Rebecca A. Moss, Monica V. Goldberg, Z. Alexander Cao, Jean-Marie Ledeine, Gregory A. Maglinte, Scott Kopetz, Thierry André
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang, Christopher J. Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A. Javed, Fay Wong, Austin K. Mattox, Ralph H. Hruban, Christopher L. Wolfgang, Michael Goggins, Marco Dal Molin, Tian‐Li Wang, Richard B.S. Roden, Alison P. Klein, Janine Ptak, Lisa Dobbyn, Joy Schaefer, Natalie Silliman, Maria Popoli, Joshua T Vogelstein, J. Dale Browne, Robert E. Schoen, Randall E. Brand, Jeanne Tie, Peter Gibbs, Hui‐Li Wong, Aaron S. Mansfield, Jin Jen, Samir Hanash, Massimo Falconi, Peter J. Allen, Shibin Zhou, Chetan Bettegowda, Luis A. Díaz, Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon, Nickolas Papadopoulos
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer
Who collaborates most closely around Peter MacCallum Cancer Centre?
ScholarIQco-authorship network
Australia
100%
MOST FREQUENT PARTNER INSTITUTIONS
How much of the research on Peter MacCallum Cancer Centre is open access?
ScholarIQopen access share
75%OPEN ACCESS